Patent Assignment
Reel/Frame 042905/0062
Release of Security Interest
Recorded: 2017-07-05
Pages: 6
Assignor
BARCLAYS BANK PLC
Executed: 2017-06-28
Assignee
DENDREON PHARMACEUTICALS LLC
1208 EASTLAKE AVENUE EAST, SEATTLE, WASHINGTON, 98102
Covered Property
(1)
Gene Expression Markers for Predicting Overall Survival in Subjects Treated with Sipuleucel-T
Application:
15/268,267 →
Publication:
US 2017/0107580
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 16, 2016
From: TRAGER, JAMES B.; SHEIKH, NADEEM A.; GUHATHAKURTA, DEBRA; KANDADI, HARINI
To: DENDREON PHARMACEUTICALS, INC.
Reel/Frame 039770/0035 →
Change of Name
May 3, 2017
From: DENDREON PHARMACEUTICALS, INC.
To: DENDREON PHARMACEUTICALS LLC
Reel/Frame 042389/0505 →
Security Agreement
May 25, 2017
From: ALDEN OPTICAL LABORATORIES, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; DENDREON PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 042584/0861 →
Corrective Assignment to Correct the Assignee Address Previously Recorded at Reel: 042389 Frame: 505. Assignor(S) Hereby Confirms the Change of Name.
Feb 14, 2018
From: DENDREON PHARMACEUTICALS, INC.
To: DENDREON PHARMACEUTICALS LLC
Reel/Frame 046088/0882 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →